Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX was delisted on the 23rd of January, 2024.
79 hedge funds and large institutions have $167M invested in Orchard Therapeutics plc American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 17 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
7% less funds holding
Funds holding: 85 → 79 (-6)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
52% less capital invested
Capital invested by funds: $351M → $167M (-$183M)
88% less call options, than puts
Call options by funds: $147K | Put options by funds: $1.25M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$9.73M |
| 2 |
Renaissance Technologies
New York
|
+$2.87M |
| 3 |
EP
Eversept Partners
New York
|
+$1.69M |
| 4 |
Millennium Management
New York
|
+$1.16M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$7.72M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$7.59M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$7.14M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$5.23M |
ORTX Hedge Fund Activity: Q3 2021 in Review
79 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q3 2021, worth a combined $167M — down 52% from $351M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ORTX and 12 opened new positions — a net loss of 5 holders — while 22 trimmed existing stakes and 27 added.
The largest buyer was Federated Hermes, adding an estimated $9.73M. The largest seller was Artisan Partners, cutting an estimated $7.72M.
- 79 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q3 2021, down from 85 in Q2 2021.
- Funds reported $167M of Orchard Therapeutics plc American Depositary Shares stock for Q3 2021, down 52% quarter-over-quarter.
- 12 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q3 2021 and 17 closed out, a net change of -5 holders.
- The largest Orchard Therapeutics plc American Depositary Shares buyer in Q3 2021 was Federated Hermes, an estimated $9.73M added.
- The largest Orchard Therapeutics plc American Depositary Shares seller in Q3 2021 was Artisan Partners, an estimated $7.72M sold.
Based on aggregated 13F filings for Q3 2021.